Calcium Fluoride PDE report and OEL report profile
Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
7789-75-5
Molecular formula
CaF2
Molecular weight
78.07 g/mol
Drug class
Inorganic fluoride saltanticaries mineral source
Mechanism of action
Provides fluoride ions that promote remineralisation of dental enamel, enhance resistance to acid dissolution and reduce enamel demineralisation. Therapeutic effects depend on the specific dental formulation and fluoride availability.
Indications / reported uses
Use as a fluoride source in selected dental materials and topical anticaries preparations; calcium fluoride is not interchangeable with all sodium-fluoride varnishes or gels and should be described only within its authorised formulation
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Calcium Fluoride PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Calcium Fluoride Permitted Daily Exposure (PDE) report (the Calcium Fluoride PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Calcium Fluoride Occupational Exposure Limit (OEL) report (the Calcium Fluoride OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.